The global industrial robotics market was valued at US$ 18.53 Bn in 2019, expanding at a CAGR of 12.1% during the forecast period from 2020 to 2028. The accelerating pace of automation is transforming a widening range of industries. Therefore, robots have made their way and are spreading throughout warehouses and manufacturing facilities around the world.
The global pneumococcal vaccines market held US$ 7,108.7 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 5.1% during the forecast period from 2021 to 2029. Pneumococcal diseases are one of the leading cause of serious illness globally resulting in high number of hospitalization every year.
Anti-aging devices market accounted for a market value of US$ 25,637.1 Mn in 2020 and projected to grow at a CAGR of 8.6% during the forecast period from 2021 to 2029. Anti-aging devices industry is changing gradually mainly assisted by increasing public awareness through promotional media and product accessibility through online sales channel.
The global endotoxin testing market is developing significantly with an expected CAGR of 8.5% from 2019 - 2029. Advances in technological processes are the key growth factor. For example: Limulus Amebocyte Lysate (LAL) test has been recommended by European and American pharmacopeia to identify bacterial endotoxins in the drugs through LAL test. This method was introduced in 1960s however, introduction on various kinds of reagents, kits and devices have simplified the process, thereby increasing the revenues and creating significant opportunities. The impact of covid 19 was severe in healthcare, though this market is not directly related to healthcare delivery institution, however, struggled due to pause on clinical trials across pharma and medical devices during the pandemic.
Growing adoption of minimally invasive procedures and enhanced safety profile of cryoablation and cryotherapy are the key factors that are determining the overall trends in the global cryotherapy devices market. These factors have led to increased adoption of cryotherapy devices in cardiology, renal conditions, pain management and tumor removal. Cryotherapy mainly involved administration through very low temperatures in surgery and chambers. Agents such as carbon dioxide, argon, liquid nitrogen and dimethyl ether propane are extensively employed in cryotherapy applications.
The growth in demand for sterilization indicators is expected to be driven by growing emphasis on refurbishing and reprocessing of medical devices for tackling the growing healthcare expenses and increasing demand for safe food and drugs.
The global medical courier market is growing steadily as a direct effect of the rising trends in the same day delivery and express delivery segment. Expansion of healthcare transportation/logistics and growing demand for faster delivery of samples and specimens for diagnostic or testing purposes generates maximum revenue share in the market.
The global high throughput screening (HTS) market is growing effectively, valued at US$ 16.01 Bn in 2020 and estimated to reach US$ 29.59 Bn by 2029. Increasing need for drug discovery in pharmaceuticals & biotechnology will enhance the overall expansion of high throughput screening market globally. New technology assessment in the field of cell based assays is significant; the fluorometric imaging plate reader cell based assays will drive the market in developed nations. New automated platforms for ultra high throughput screening will gain traction globally.
The dilated cardiomyopathy therapeutics market is set to reach US$ xx Mn by 2033 from US$ xx Mn in 2021 featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2025 to 2033. As per the latest research citings of World Health Organization (WHO), annually 17.9 million people die throughout the globe from cardiovascular diseases which is equivalent o 31% of all global deaths. Factors responsible for congestive heart failure are sedentary lifestyle, obesity, unhealthy lifestyle and congenital heart complications.
The global chromatography systems market is growing fruitfully, valued at US$ 7.5 Bn in 2020 and expected to reach US$ 13.79 Bn by 2029. Worldwide increasing need for separation analysis in pharmaceuticals, environmental/water, biotechnology, food & agriculture applications will enhance the overall growth of the chromatography systems globally.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
